EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis. (2021)

First Author: Agache I

Attributed to: Cutaneous Immunology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.14690

PubMed Identifier: 33538044

Publication URI: http://europepmc.org/abstract/MED/33538044

Type: Journal Article/Review

Volume: 76

Parent Publication: Allergy

Issue: 4

ISSN: 0105-4538